|Craig-Hallum Capital Group||Alexander Nowak|
|Guggenheim Securities, LLC||Etzer Darout, PhD|
|Lake Street Capital Markets||Thomas Flaten|
|Maxim Group, LLC||Jason McCarthy|
|Oppenheimer & Co. Inc.||Francois Brisebois|
|ROTH Capital Partners||Elemer Piros, PhD|
DiaMedica Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding DiaMedica Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of DiaMedica Therapeutics, Inc. or its management. DiaMedica Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.